C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) C07K 14/705 (2006.01) C12N 15/10 (2006.01) C12N 15/85 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2547635
Novel MUC-1 epitopes outside the VNTR region are identified. In addition, the first agonist epitope of MUC-1 is described. The employment of agonist epitopes in peptide, protein and vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers.
Selon l'invention, de nouveaux épitopes de MUC-1 situés à l'extérieur de la région VNTR sont identifiés. De plus, le premier épitope agoniste de MUC-1 est décrit. L'utilisation d'épitopes agonistes dans des vaccins à base de peptides, de protéines et de vecteurs peut contribuer au développement de vaccins efficaces pour une pluralité de cancers humains.
Schlom Jeffrey
Tsang Kwong-Yok
Department Of Health And Human Services Government Of The United States Of America As Represented By The
Robic
LandOfFree
A human cytotoxic t-lymphocyte epitope and its agonist... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A human cytotoxic t-lymphocyte epitope and its agonist..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A human cytotoxic t-lymphocyte epitope and its agonist... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1794304